Please provide your email address to receive an email when new articles are posted on . The AD2 blood test was roughly 90% accurate at Alzheimer’s identification. Diagnoses of subjective cognitive ...

A commercially available plasma assay that measured phosphorylated tau at threonine 217 (p-tau217) accurately identified biological Alzheimer's disease, data from three cohorts showed. Across all ...

A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...

BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a diagnostics brand of Quanterix Corporation (NASDAQ: QTRX), today announced expansion of its LucentAD product line with the addition of a high ...

AUSTIN, Texas--(BUSINESS WIRE)--Veravas, a leading innovator in clinical diagnostics, today announced the results of an analytical verification study of its VeraBIND™ Tau assay, a next-generation test ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

Please provide your email address to receive an email when new articles are posted on . Researchers assessed 201 individuals with a digital cognitive test and blood-based biomarkers for Alzheimer’s ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

UAB Pathology and the Division of Genomic Diagnostics and Bioinformatics are pleased to announce a new, state-of-the-art Next Generation Sequencing (NGS) Cancer Assay, now available in the UAB ...

Researchers have used off-the-shelf components to create a sensor device that is not only cost-effective but can quickly detect 32 different pathogens and has sensitivities on par with the ...